Abstract:The specific spatiotemporal distribution of diverse components in tumor microenvironment plays a crucial role in the cancer progression.In vitrothree-dimensional (3D) tumor models with polydimethylsiloxane (PDMS) based microfluidic platform have been applied as useful tool to conduct studies from cancer biology to drug screening. However, PDMS has not been welcomed as a standardized commercial application for preclinical screening due to inherent limitations in scale-up production and molecule absorption. Here, we present a novel microfluidic platform to flexibly construct 3D co-culture models with spatiotemporal resolution by using multiple digital manufacturing technologies. The platform, which consist of reduplicative microfluidic chips, is made of biocompatible poly methyl methacrylate by fast laser cutting. Each replica includes a simple microfluidic chamber without internal structures which can be flexibly post-fabricated according to various research requirements. Digital light processing based 3D bioprinting was used to pattern fine hydrogel structures for post-fabrication on-chip. By multi-step bioprinting and automatic image alignment, we show that this approach provides sufficient design flexibility to construct 3D co-culture tumor model with spatiotemporal resolution to replicate microarchitecture of tumor microtissuein situ. And the tumor model has the potential to mimic tumor biology behaviors which can be used for mechanism study and drug test. Our microengineered tumor model may serve as an enabling tool to recapitulate pathophysiological complexity of tumor, and to systematically examine the contribution of the tumor microenvironment to the cancer progression. The proposed strategy can also be applied to help engineer diverse meaningfulin vitromodels for extensive biomedical applications, from physiology and disease study to therapy evaluation.

Bi-layer Blood Vessel Mimicking Microfluidic Platform for Antitumor Drug Screening Based on Co-Culturing 3D Tumor Spheroids and Endothelial Layers.

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Bioprinting of Novel 3D Tumor Array Chip for Drug Screening

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

A Microfluidic Platform for Multi-Size 3D Tumor Culture, Monitoring and Drug Resistance Testing

Integrated Microfluidic Platform with Multiple Functions To Probe Tumor-Endothelial Cell Interaction.

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

Large-Scale Antitumor Screening Based on Heterotypic 3D Tumors Using an Integrated Microfluidic Platform.

Establishment of an in Vitro Three-Dimensional Vascularized Micro-Tumor Model and Screening of Chemotherapeutic Drugs

A Tumor‐on‐a‐Chip System with Bioprinted Blood and Lymphatic Vessel Pair

An Integrated Microfluidic 3D Tumor System for Parallel and High-Throughput Chemotherapy Evaluation

Integrated microfluidic system for cell co-culture and simulation of drug metabolism

Modeling Endothelialized Hepatic Tumor Microtissues for Drug Screening

A Perfused Two-Chamber System For Anticancer Drug Screening

Microfluidic Formation of Coculture Tumor Spheroids with Stromal Cells As a Novel 3D Tumor Model for Drug Testing

Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery

Microfluidics‐Molded Through‐Hole Membranes for 3D Culture Array‐Based Tumor Manipulation and Analysis

A Digital Manufactured Microfluidic Platform for Flexible Construction of 3D Co-Culture Tumor Model with Spatiotemporal Resolution

Long-term cultured microvascular networks on chip for tumor vascularization research and drug testing

A Novel 3D Breast-Cancer-on-chip Platform for Therapeutic Evaluation of Drug Delivery Systems.

Tumor Microenvironment Based on Extracellular Matrix Hydrogels for On-Chip Drug Screening